Professor Karen Lam, MBBS (Hon.) MRCP(UK) MD (HK), FRCP (Edin and Lond), FRACP, FHKCP, FHKAM (Medicine)

Chairman, Committee of Management, Clinical Trials Centre, The University of Hong Kong

Head, Department of Medicine, The University of Hong Kong

Rosie TT Young Professor in Endocrinology and Metabolism

Chair Professor in Medicine, The University of Hong Kong

Clinical Director, State Key Laboratory of Pharmaceutical Biotechnology

Director, Research Centre of Heart, Brain, Hormone & Healthy Aging, The University of Hong Kong

Founding Director, KK Leung Diabetes Centre, Queen Mary Hospital

Founding President, Diabetes Hong Kong

Honorary Consultant, Queen Mary Hospital

Hong Kong, China
 
Biography:
 
Professor Karen Lam is Chair Professor in Medicine, Director of the Research Centre in Heart, Brain, Hormone & Healthy Aging, Clinical Director of the State Key Lab of Pharmaceutical & Biotechnology and Chairman of the Clinical Trial Centre at the University of Hong Kong (HKU). She is also the Department Head and Chief of Endocrinology at the University Department of Medicine, Queen Mary Hospital.
 
Professor Lam was the Founding President of Diabetes Hongkong (Honorary President since 2014), a past president of the Hong Kong Society of Endocrine, Metabolism and Reproduction, and past Chairman of two specialty boards of the HK College of Physicians – Advanced Internal Medicine and Endocrinology, Diabetes & Metabolism. She is currently the associate editor/editorial board member of several international peer-reviewed journals in diabetes and endocrinology.
 
Professor Lam has published extensively on clinical, basic and translational research in diabetes and endocrinology, including publications in Diabetes, Diabetes Care, Diabetologia, JCEM, Hypertension, ATVB, Circulation, Annals of Internal Medicine, Endocrinology, JBC, PNAS, JCI and Lancet. Her current research focuses on the role of adipocyte derived hormones in diabetes and other obesity-related cardiometabolic disorders. Her team has established two large cohorts, the CRISPS and HKW Diabetes Registry, for prospective studies on the genetic and environmental determinants of diabetes and its related medical problems. More recently she has steered the establishment of the HKU Phase 1 Clinical Trial Centre at the Queen Mary Hospital.
 
Session:
 
20th November 2015 (Friday) 16:00 – 17:15
 
Dr. Cheng Yu Tung Award Lecture in Drug Development